Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,332 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants.
Chen M, Pekosz A, Villano JS, Shen W, Zhou R, Kulaga H, Li Z, Smith A, Gurung A, Beck SE, Witwer KW, Mankowski JL, Ramanathan M Jr, Rowan NR, Lane AP. Chen M, et al. Among authors: zhou r. J Clin Invest. 2024 Mar 14;134(8):e174439. doi: 10.1172/JCI174439. J Clin Invest. 2024. PMID: 38483537 Free PMC article.
Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants.
Chen M, Pekosz A, Villano JS, Shen W, Zhou R, Kulaga H, Li Z, Beck SE, Witwer KW, Mankowski JL, Ramanathan M Jr, Rowan NR, Lane AP. Chen M, et al. Among authors: zhou r. bioRxiv [Preprint]. 2022 Apr 12:2022.04.12.487379. doi: 10.1101/2022.04.12.487379. bioRxiv. 2022. PMID: 35441175 Free PMC article. Updated. Preprint.
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants.
Jiang L, Driedonks TAP, Jong WSP, Dhakal S, van den Berg van Saparoea HB, Sitaras I, Zhou R, Caputo C, Littlefield K, Lowman M, Chen M, Lima G, Gololobova O, Smith B, Mahairaki V, Richardson MR, Mulka KR, Lane AP, Klein SL, Pekosz A, Brayton CF, Mankowski JL, Luirink J, Villano JS, Witwer KW. Jiang L, et al. Among authors: zhou r. bioRxiv [Preprint]. 2022 Feb 1:2021.06.28.450181. doi: 10.1101/2021.06.28.450181. bioRxiv. 2022. PMID: 35132418 Free PMC article. Updated. Preprint.
Sex differences in lung imaging and SARS-CoV-2 antibody responses in a COVID-19 golden Syrian hamster model.
Dhakal S, Ruiz-Bedoya CA, Zhou R, Creisher P, Villano J, Littlefield K, Castillo J, Marinho P, Jedlicka A, Ordonez A, Majewska N, Betenbaugh M, Flavahan K, Mueller A, Looney M, Quijada D, Mota F, Beck SE, Brockhurst JK, Braxton A, Castell N, D'Alessio F, Metcalf Pate KA, Karakousis PC, Mankowski JL, Pekosz A, Jain SK, Klein SL. Dhakal S, et al. Among authors: zhou r. bioRxiv [Preprint]. 2021 Apr 4:2021.04.02.438292. doi: 10.1101/2021.04.02.438292. bioRxiv. 2021. PMID: 33821269 Free PMC article. Updated. Preprint.
Limitations of molecular and antigen test performance for SARS-CoV-2 in symptomatic and asymptomatic COVID-19 contacts.
Robinson ML, Mirza A, Gallagher N, Boudreau A, Garcia L, Yu T, Norton J, Luo CH, Conte A, Zhou R, Kafka K, Hardick J, McManus DD, Gibson LL, Pekosz A, Mostafa H, Manabe YC. Robinson ML, et al. Among authors: zhou r. medRxiv [Preprint]. 2022 Feb 7:2022.02.05.22270481. doi: 10.1101/2022.02.05.22270481. medRxiv. 2022. PMID: 35169814 Free PMC article. Updated. Preprint.
Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution.
Ke R, Martinez PP, Smith RL, Gibson LL, Achenbach CJ, McFall S, Qi C, Jacob J, Dembele E, Bundy C, Simons LM, Ozer EA, Hultquist JF, Lorenzo-Redondo R, Opdycke AK, Hawkins C, Murphy RL, Mirza A, Conte M, Gallagher N, Luo CH, Jarrett J, Conte A, Zhou R, Farjo M, Rendon G, Fields CJ, Wang L, Fredrickson R, Baughman ME, Chiu KK, Choi H, Scardina KR, Owens AN, Broach J, Barton B, Lazar P, Robinson ML, Mostafa HH, Manabe YC, Pekosz A, McManus DD, Brooke CB. Ke R, et al. Among authors: zhou r. medRxiv [Preprint]. 2021 Sep 2:2021.08.30.21262701. doi: 10.1101/2021.08.30.21262701. medRxiv. 2021. PMID: 34494028 Free PMC article. Updated. Preprint.
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia.
Rosenson RS, Gaudet D, Hegele RA, Ballantyne CM, Nicholls SJ, Lucas KJ, San Martin J, Zhou R, Muhsin M, Chang T, Hellawell J, Watts GF; ARCHES-2 Trial Team. Rosenson RS, et al. Among authors: zhou r. N Engl J Med. 2024 May 29. doi: 10.1056/NEJMoa2404147. Online ahead of print. N Engl J Med. 2024. PMID: 38809174
8,332 results